Blanca H.
- Country
- Spain
- Department
- Pediatrics
Research Overview
- Early Discontinuation of Antibiotic Therapy in High-Risk Febrile Neutropenic Pediatric Oncology Patients
- ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) with Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
- Phase 2 Evaluation of Varnimcabtagene Autoleucel in Pediatric CD19+ Acute Lymphoblastic Leukemia Resistant or Refractory to Standard Therapies
Data & Insights
Has run more than one trial at 72 of 175 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating acute lymphoblastic leukemia in children and adolescents, with particular focus on developing innovative cellular therapies for resistant cases.
- Pediatric blood cancers
- Refractory leukemia treatment
- Cellular immunotherapy
Their expertise extends to managing complex cases of treatment-resistant leukemia in young patients.
Cell Therapy Development
The investigator focuses on advanced T-cell therapy approaches, particularly working with engineered immune cells for targeting specific cancer markers.
- CAR T-cell therapy
- Autologous cell processing
- Lentiviral vector technology
Their work involves developing personalized cellular treatments using modified immune cells.
Immunotherapy Research
The investigator's work centers on chimeric antigen receptor technology and its applications in treating aggressive blood cancers.
- CD19-targeted therapy
- Immune system modification
- Novel therapeutic approaches
Their research encompasses innovative immunological strategies for treating resistant blood cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.